**Core Concept**
The question is testing the association between genetic predisposition and endometrial carcinoma, specifically focusing on the endometrioid type. Endometrial carcinoma is a common gynecological malignancy, and genetic factors play a crucial role in its development.

**Why the Correct Answer is Right**
The endometrioid type of endometrial carcinoma is often associated with mutations in the PTEN gene. PTEN (phosphatase and tensin homolog) is a tumor suppressor gene that regulates the PI3K/AKT signaling pathway, which is involved in cell growth and survival. Mutations in PTEN lead to loss of its function, resulting in uncontrolled cell growth and tumor formation.

**Why Each Wrong Option is Incorrect**
* **Option A:** Mutations in the TP53 gene are commonly associated with other types of cancers, such as breast and lung cancer, but are less frequently implicated in endometrial carcinoma.
* **Option B:** Mutations in the BRCA1 and BRCA2 genes are primarily associated with breast and ovarian cancer, and are not the primary genetic defect in endometrial carcinoma.
* **Option C:** Mutations in the KRAS gene are more commonly associated with colorectal cancer, and are not a primary genetic defect in endometrial carcinoma.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that endometrial carcinoma is often associated with genetic predisposition, particularly in women with a family history of the disease. A thorough family history and genetic counseling may be necessary to identify individuals at high risk.

**Correct Answer:** C. PTEN gene mutation.